Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S B
(OP:
NONOF
)
114.04
UNCHANGED
Streaming Delayed Price
Updated: 3:49 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
114.04
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
114.04
Today's Range
114.04 - 114.04
52wk Range
89.94 - 149.55
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition
June 24, 2024
The greater weight loss in women did not result in significantly better improvements in heart failure symptoms.
Via
Benzinga
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
June 21, 2024
As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide.
Via
Benzinga
Performance
YTD
+12.69%
+12.69%
1 Month
-14.60%
-14.60%
3 Month
-20.94%
-20.94%
6 Month
-8.59%
-8.59%
1 Year
+26.51%
+26.51%
More News
Read More
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
June 07, 2024
Via
InvestorPlace
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments
May 14, 2024
Via
Benzinga
7 Mutual Funds That Will Outperform in Any Market
February 03, 2024
Via
InvestorPlace
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label
September 11, 2023
Via
Benzinga
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector
November 23, 2023
Via
Benzinga
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
October 09, 2023
Via
Benzinga
Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian
July 03, 2023
Via
Benzinga
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert
August 17, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.